Next Article in Journal
Biological Roles of Protein-Coding Tandem Repeats in the Yeast Candida Albicans
Next Article in Special Issue
Mangrove-Associated Fungi: A Novel Source of Potential Anticancer Compounds
Previous Article in Journal
Estimated Burden of Serious Fungal Diseases in Serbia
Previous Article in Special Issue
Antiplasmodial Properties and Cytotoxicity of Endophytic Fungi from Symphonia globulifera (Clusiaceae)
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessReview
J. Fungi 2018, 4(3), 77; https://doi.org/10.3390/jof4030077

Endophytic Fungi: A Source of Potential Antifungal Compounds

1
TERI-Deakin Nano Biotechnology Centre, The Energy and Resources Institute (TERI), Darbari Seth Block, IHC Complex, Lodhi Road, New Delhi 110003, India
2
Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, India
3
Department of Biotechnology, Thapar Institute of Engineering & Technology, Deemed to be a University, Patiala, Punjab 147004, India
*
Author to whom correspondence should be addressed.
Received: 20 May 2018 / Revised: 13 June 2018 / Accepted: 16 June 2018 / Published: 25 June 2018
(This article belongs to the Special Issue Fungal Endophytes in Plants)
Full-Text   |   PDF [2405 KB, uploaded 25 June 2018]   |  

Abstract

The emerging and reemerging forms of fungal infections encountered in the course of allogeneic bone marrow transplantations, cancer therapy, and organ transplants have necessitated the discovery of antifungal compounds with enhanced efficacy and better compatibility. A very limited number of antifungal compounds are in practice against the various forms of topical and systemic fungal infections. The trends of new antifungals being introduced into the market have remained insignificant while resistance towards the introduced drug has apparently increased, specifically in patients undergoing long-term treatment. Considering the immense potential of natural microbial products for the isolation and screening of novel antibiotics for different pharmaceutical applications as an alternative source has remained largely unexplored. Endophytes are one such microbial community that resides inside all plants without showing any symptoms with the promise of producing diverse bioactive molecules and novel metabolites which have application in medicine, agriculture, and industrial set ups. This review substantially covers the antifungal compounds, including volatile organic compounds, isolated from fungal endophytes of medicinal plants during 2013–2018. Some of the methods for the activation of silent biosynthetic genes are also covered. As such, the compounds described here possess diverse configurations which can be a step towards the development of new antifungal agents directly or precursor molecules after the required modification. View Full-Text
Keywords: endophytic fungi; antifungal compounds; medicinal plants; co-culture; epigenetic modification endophytic fungi; antifungal compounds; medicinal plants; co-culture; epigenetic modification
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed
Printed Edition Available!
A printed edition of this Special Issue is available here.

Share & Cite This Article

MDPI and ACS Style

Deshmukh, S.K.; Gupta, M.K.; Prakash, V.; Saxena, S. Endophytic Fungi: A Source of Potential Antifungal Compounds. J. Fungi 2018, 4, 77.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Fungi EISSN 2309-608X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top